» Authors » Orlin Belyaev

Orlin Belyaev

Explore the profile of Orlin Belyaev including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 84
Citations 896
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fahlbusch T, Tafelmeier A, Slobodkin I, Uhl W, Belyaev O
J Vis Exp . 2025 Feb; (216). PMID: 39995187
Robotic-assisted surgery has become increasingly popular since the introduction of the first robotic platform. Recently, a modular robotic system was approved for in-human use in Europe. Possible applications for this...
2.
Belyaev O, Fahlbusch T, Slobodkin I, Uhl W
J Clin Med . 2024 Jul; 13(13). PMID: 38999244
The versatile open modular design of the newly introduced robotic platform Hugo RAS is expected to allow its rapid spread in general surgery. However, the system is not yet approved...
3.
Belyaev O, Fahlbusch T, Slobodkin I, Uhl W
Updates Surg . 2024 Jul; 76(5):1705-1714. PMID: 38980596
The recently introduced Hugo RAS robotic platform has mostly been used for well standardized urologic and gynaecologic procedures. Experience with this new system in general surgery and especially in major...
4.
Petrikowski M, Fahlbusch T, Reinacher-Schick A, Kucinskaite G, Tannapfel A, Uhl W, et al.
Hepatobiliary Surg Nutr . 2024 Jun; 13(3):460-471. PMID: 38911210
Background: The establishment of preoperative chemotherapy (PCT) with FOLFIRINOX and gemcitabine/nab-paclitaxel in recent years has enabled resectability in many patients with initially locally advanced pancreatic cancer (LAPC). Nevertheless, information about...
5.
Ten Winkel M, Salama H, Timrott K, Kleine M, Kleine-Doepke D, Raehder-Johnson S, et al.
Pancreatology . 2024 Feb; 24(2):314-322. PMID: 38310036
Background/objectives: Pancreatic surgery may have a long-lasting effect on patients' health status and quality of life (QoL). We aim to evaluate patient-reported outcomes (PRO) 3 months after pancreatic surgery. Methods:...
6.
Belyaev O, Fahlbusch T, Slobodkin I, Uhl W
Visc Med . 2023 Oct; 39(3-4):76-86. PMID: 37901385
Introduction: The Hugo RAS robotic platform by Medtronic was recently certified for human use in Europe. Several centers have gained initial experience with this system in urology and gynecology. However,...
7.
Uranues S, Fingerhut A, Belyaev O, Zerbi A, Boggi U, Hoffmann M, et al.
Ann Surg Open . 2023 Aug; 2(1):e033. PMID: 37638240
Introduction: Postoperative pancreatic fistula (POPF) is the most dreaded complication after distal pancreatectomy (DP). This multicenter randomized trial evaluated the efficacy, safety, and tolerance of Hemopatch in preventing clinically relevant...
8.
Mintziras I, Stollenwerk L, Uhl W, Niescery J, Belyaev O, Luu A, et al.
Pancreas . 2023 Apr; 51(9):1128-1132. PMID: 37078935
Objectives: Patient characteristics with postoperative acute necrotizing pancreatitis and completion pancreatectomy (CP) after pancreaticoduodenectomy (PD) remain unclear. Methods: Data from all patients who underwent a PD with need for CP...
9.
Hohn P, Runde F, Luu A, Fahlbusch T, Fein D, Klinger C, et al.
BJS Open . 2023 Mar; 7(2). PMID: 36882081
Introduction: Surgical risk calculators can estimate risk probabilities for postoperative outcomes utilizing patient-specific risk factors. They provide meaningful information for obtaining informed consent. The aim of the present paper was...
10.
Aghalarov I, Beyer E, Niescery J, Belyaev O, Uhl W, Herzog T
HPB (Oxford) . 2023 Feb; 25(6):667-673. PMID: 36842945
Background: Postoperative pancreatic fistula (POPF) as well as postoperative biliary fistula (POBF) are considered the main source of postoperative morbidity and mortality after pancreatoduodenectomy (PD). However, little is known about...